Unknown NA INTERVENTIONAL 1-arm NCT02966574

Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic Cancers

Sponsor: Brugmann University Hospital

Updated 9 times since 2017 Last updated: Jan 15, 2020 Started: Dec 13, 2016 Primary completion: Dec 30, 2020 Completion: Dec 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Metastatic Breastcancer and is currently ongoing. Brugmann University Hospital leads this study, which shows 9 recorded versions since 2016 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Mar 2022 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Mar 2022 [monthly]

Recruiting NA
Feb 2020 — Jan 2021 [monthly]

Recruiting NA

▶ Show 4 earlier versions

Sep 2018 — Feb 2020 [monthly]

Recruiting NA
Aug 2018 — Sep 2018 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jun 2018 — Aug 2018 [monthly]

Not Yet Recruiting NA
Jan 2017 — Jun 2018 [monthly]

Not Yet Recruiting NA

First recorded

Dec 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Brugmann University Hospital

Data source: Brugmann University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brussels, Belgium